Indian Pediatrics

, Volume 48, Issue 11, pp 879–887 | Cite as

Juvenile systemic lupus erythematosus: Review of clinical features and management

Review Article
First Online:

Keywords

Systemic Lupus Erythematosus Nephritis Lupus Nephritis Mycophenolate Mofetil INDIAN Pediatric 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Petty RE, Laxer RM. Systemic lupus erythematosus. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB. editors. Textbook of Pediatric Rheumatology. Philadelphia, PA: Elsiever Saunders; 2005. p. 342–391.CrossRefGoogle Scholar
  2. 2.
    Brunner HI, Gladman DD, Ibanez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58:556–562.PubMedCrossRefGoogle Scholar
  3. 3.
    Font J, Cervera R, Espinosa G, Pallarés L, Ramos-Casals M, Jiménez S, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis. 1998;57:456–459.PubMedCrossRefGoogle Scholar
  4. 4.
    Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adultonset systemic lupus erythematosus. Arthritis Rheum. 2009;61:13–20.PubMedGoogle Scholar
  5. 5.
    Hoffman IE, Lauwerys BR, De Keyser F, Huizinga TW, Isenberg D, Cebecauer L, et al. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis. 2009;68:412–415.PubMedCrossRefGoogle Scholar
  6. 6.
    Rood MJ, ten Cate R, van Suijlekom-Smit LW, den Ouden EJ, Ouwerkerk FE, Breedveld FC, et al. Childhood-onset Systemic Lupus Erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol. 1999;28:222–226.PubMedCrossRefGoogle Scholar
  7. 7.
    Tucker LB, Menon S, Schaller JG, Isenberg DA. Adultand childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol. 1995;34:866–872.PubMedCrossRefGoogle Scholar
  8. 8.
    Tucker LB, Uribe AG, Fernandez M, Vilá LM, McGwin G, Apte M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus. 2008;17:314–322.PubMedCrossRefGoogle Scholar
  9. 9.
    Mina R, Brunner HI. Peadiatric Lupus- are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus. Rheum Dis Clin N Am. 2010;36:53–80.CrossRefGoogle Scholar
  10. 10.
    Serdula MK, Rhoads GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum. 1979;22:328–333.PubMedCrossRefGoogle Scholar
  11. 11.
    Huang JL, Yao TC, See LC. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol. 2004;22:776–780.PubMedGoogle Scholar
  12. 12.
    Kurahara DK, Grandinetti A, Fujii LL, Tokuda AA, Galario JA, Han MJ, et al. Visiting consultant clinics to study prevalence rates of juvenile rheumatoid arthritis and childhood systemic lupus erythematosus across dispersed geographic areas. J Rheumatol. 2007;34:425–429.PubMedGoogle Scholar
  13. 13.
    Malaviya AN, Singh RR, Singh YN, Kapoor SK, Kumar A. Prevalence of systemic lupus erythematosus in India. Lupus. 1993;2:115–118.PubMedCrossRefGoogle Scholar
  14. 14.
    Samanta A, Roy S, Feehally J, Symmons DP. The prevalence of systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br J Rheumatol. 1992;31:679–682.PubMedCrossRefGoogle Scholar
  15. 15.
    Mondal R, Nandi M, Ganguli S, Ghosh A, Hazra A. Childhood Lupus: Experience from Eastern India. Indian J Pediatr. 2010 Aug 24. [Epub ahead of print]Google Scholar
  16. 16.
    Hochberg MC. Updating the American College of Rheumatology criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.PubMedCrossRefGoogle Scholar
  17. 17.
    Carreno L, Lopez-Longo FJ, Monteagudo I, Rodríguez-Mahou M, Bascones M, González CM, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus. 1999;8:287–292.PubMedCrossRefGoogle Scholar
  18. 18.
    Pande I, Sekharan NG, Kailash S, Uppal SS, Singh RR, Kumar A, et al. Analysis of clinical and laboratory profile in Indian childhood systemic lupus erythematosus and its comparison with SLE in adults. Lupus. 1993;2:83–87.PubMedCrossRefGoogle Scholar
  19. 19.
    Kumar S, Nair S, Rajam L. Case series of pediatric systemic lupus erythematosus from Kerala: comparison with other Indian series. Int J Rheum Dis. 2010;13:391–395.PubMedCrossRefGoogle Scholar
  20. 20.
    Zappitelli M, Duffy CM, Bernard C, Gupta IR. Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol. 2008;23:83–91.PubMedCrossRefGoogle Scholar
  21. 21.
    Cameron JS. Lupus nephritis in childhood and adolescence. Paediatr Nephrol. 1994;8:230–249.CrossRefGoogle Scholar
  22. 22.
    Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15:241–250.PubMedCrossRefGoogle Scholar
  23. 23.
    Elliot V, Cairns T, Cook HT. Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis. Am J Kidney Dis. 2006;47:184–190.PubMedCrossRefGoogle Scholar
  24. 24.
    Spronk PE, ter Borg EJ, Kallenberg CG. Patients with systemic lupus erythematosus and Jaccoud’s arthropathy: a clinical subset with an increased C reactive protein response? Ann Rheum Dis. 1992;51:358–361.PubMedCrossRefGoogle Scholar
  25. 25.
    Perilloux BC, Shetty AK, Leiva LE, Gedalia A. Antinuclear antibody (ANA) and ANA profile tests in children with autoimmune disorders: a retrospective study. Clin Rheumatol. 2000;19:200–203.PubMedCrossRefGoogle Scholar
  26. 26.
    Cross LS, Aslam A, Misbah SA. Antinuclear antibody negative lupus as a distinct diagnostic entity. Does it no longer exist. QJM. 2004;97:303–308.PubMedCrossRefGoogle Scholar
  27. 27.
    Cabral DA, Petty RE, Fung M, Malleson P. Persistent antinuclear antibodies in children without identifiable rheumatic or autoimmune disease. Pediatrics. 1992;89:441–444.PubMedGoogle Scholar
  28. 28.
    Deane PMG, Liard G, Siegel DM, Baum J. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics. 1995;95:892–895.PubMedGoogle Scholar
  29. 29.
    Esdaile JM, Abrahamowicz M, Joseph L, MacKenzie T, Li Y, Danoff D. Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. Arthritis Rheum. 1996;39:370–378.PubMedCrossRefGoogle Scholar
  30. 30.
    Breda L, Nozzi M, De Sanctis S, Chiarelli F. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update. Semin Arthritis Rheum. 2009;40:53–72.PubMedCrossRefGoogle Scholar
  31. 31.
    Jurencak R, Fritzler M, Tyrrell P, Hiraki L, Benseler S, Silverman E. Autoantibodies in paediatric systemic lupus erythematosus: ethnic grouping, cluster analysis and clinical correlation. J Rheumatol. 2009;36:416–421.PubMedCrossRefGoogle Scholar
  32. 32.
    Leana W, Atkinson JP, Giclas PC. Clinical and laboratory evaluation of complement deficiency. J Allergy and Clin Immunol. 2004;113:585–593.CrossRefGoogle Scholar
  33. 33.
    Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G. Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci. 2009;1173:47–51.PubMedCrossRefGoogle Scholar
  34. 34.
    Silverman E, Mamula M, Hardin JA, Laxer R. Importance of the immune response to the Ro/La particle in the development of congenital heart block and neonatal lupus erythematosus. J Rheumatol. 1991;18:120–124.PubMedGoogle Scholar
  35. 35.
    Julkunen H, Kaaja R, Wallgren E, Teramo K. Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block. Obstet Gynecol. 1993;82:11–16.PubMedGoogle Scholar
  36. 36.
    Buyon JP, Heibert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune associated congetnital-heart block: demographics, mortality, morbidity and recurrence rates obtained from a natonal neonatal lupus registry. J Am Coll Cardiol. 1998;31:1658–1666.PubMedCrossRefGoogle Scholar
  37. 37.
    Tsakonas E, Joseph L, Esdaile JM, Choquette D, Senécal JL, Cividino A, et al. A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. Lupus. 1998;7:80–85.PubMedCrossRefGoogle Scholar
  38. 38.
    Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010;69:20–28.PubMedCrossRefGoogle Scholar
  39. 39.
    Barbano G, Gusmano R, Damasio B, Alpigiani MG, Buoncompagni A, Gattorno M, et al. Childhood-onset lupus nephritis: a single-center experience of pulse intravenous cyclophosphamide therapy. J Nephrol. 2002;15:123–129.PubMedGoogle Scholar
  40. 40.
    Lehman TJ, Onel K. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr. 2000;136:243–247.PubMedCrossRefGoogle Scholar
  41. 41.
    Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol. 2001;28:2103–2108.PubMedGoogle Scholar
  42. 42.
    Fu YF, Liu GL. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine. Clin Nephrol. 2001;55:318–321.PubMedGoogle Scholar
  43. 43.
    Kazyra I, Pilkington C, Marks SD, Tullus K. Mycophenolate mofetil treatment in children and adolescents with lupus. Arch Dis Child. 2010;95:1059–1061.PubMedCrossRefGoogle Scholar
  44. 44.
    Baca V, Catalán T, Villasís-Keever M, Ramón G, Morales AM, Rodríguez-Leyva F. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhoodonset lupus nephritis. Lupus. 2006;15:490–495.PubMedCrossRefGoogle Scholar
  45. 45.
    Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study. Lupus 2007;16:896–900.PubMedCrossRefGoogle Scholar
  46. 46.
    Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, et al. Long-term follow-up of childhood lupus nephritis. J Rheumatol. 2002;29:2635–2642.PubMedGoogle Scholar
  47. 47.
    Lionaki S, Kapitsinou PP, Iniotaki A, Kostakis A, Moutsopoulos HM, Boletis JN. Kidney transplantation in lupus patients: a case-control study from a single centre. Lupus. 2008;17:670–675.PubMedCrossRefGoogle Scholar
  48. 48.
    Moroni G, Tantardini F, Gallelli B, Quaglini S, Banfi G, Poli F, et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis. 2005;45:903–911.PubMedCrossRefGoogle Scholar
  49. 49.
    Baca V, Lavalle C, Garcia R, Catalán T, Sauceda JM, Sánchez G, et al. Favourable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric Lupus. J Rheumatol. 1999;26:432–439.PubMedGoogle Scholar
  50. 50.
    Levy DM, Massicotte MP, Harvey E, Hebert D, Silverman ED. Thromboembolism in paediatric lupus patients. Lupus. 2003;12:741–746.PubMedCrossRefGoogle Scholar
  51. 51.
    Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010;62:222–233.PubMedCrossRefGoogle Scholar
  52. 52.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Baldovino S, et al. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy. Nephrol Dial Transplant 2011 Mar 8. [Epub ahead of print].Google Scholar
  53. 53.
    Pottier V, Pierrot M, Subra JF, Mercat A, Kouatchet A, Parrot A, et al. Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage. Lupus. 2011 Feb 18. [Epub ahead of print]Google Scholar
  54. 54.
    Gonzalez B, Hernandez P, Olguin H, Miranda M, Lira L, Toso M, et al. Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years’ experience in Chile. Lupus. 2005;14:918–923.PubMedCrossRefGoogle Scholar
  55. 55.
    Doria A, Iaccarino L, Ghirardello A, Zampieri S, Arienti S, Sarzi-Puttini P, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med. 2006;119:700–706.PubMedCrossRefGoogle Scholar
  56. 56.
    Glidden RS, Mantzouranis EC, Borel Y. Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients. Clin Immunol Immunopathol. 1983;29:196–210.PubMedCrossRefGoogle Scholar
  57. 57.
    Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2550–2557.PubMedCrossRefGoogle Scholar
  58. 58.
    Brunner HI, Sherrard TM, Klein-Gitelman MS. Cost of treatment of childhood onset systemic lupus erythematosus. Arthritis Rheum. 2006;55:184–188.PubMedCrossRefGoogle Scholar
  59. 59.
    Sutcliffe N, Clarke AE, Taylor R, Frost C, Isenberg DA. Total costs and predictors of costs in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2001;40:37–47.CrossRefGoogle Scholar
  60. 60.
    Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52:514–521.PubMedCrossRefGoogle Scholar
  61. 61.
    Saar P, Hermann W, Müller-Ladner U. Connective tissue diseases and pregnancy. Rheumatology. 2006;45:Siii30–Siii32.CrossRefGoogle Scholar
  62. 62.
    Mok CC, Wong RW. Pregnancy in systemic lupus erythematosus. Postgrad Med J. 2001;77:157–165.PubMedCrossRefGoogle Scholar
  63. 63.
    Silva CA, Hilario MO, Febronio MV, Oliveira SK, Almeida RG, Fonseca AR, et al. Pregnancy outcome in juvenile systemic lupus erythematosus: A Brazilian multicenter cohort study. J Rheumatol. 2008;35:1414–1418.PubMedGoogle Scholar

Copyright information

© Indian Academy of Pediatrics 2011

Authors and Affiliations

  1. 1.Department of Pediatric Nephrology, Academic Renal UnitUniversity of BristolBristolUK
  2. 2.Department of Pediatric Rheumatology, Honorary ReaderUniversity of Bristol, Bristol Royal Hospital for Children and Royal National Hospital for Rheumatic DiseasesBathUK
  3. 3.Department of RheumatologyNizams Institute of Medical SciencesHyderabadIndia
  4. 4.Department of Pediatric Rheumatology, Upper Maudlin StreetBristol Royal Hospital for ChildrenBristolUK

Personalised recommendations